Expression of SKALP/elafin in Oesophageal Cancer
Author Information
Author(s): S Yamamoto, H Egami, T Kurizaki, H Ohmachi, N Hayashi, T Okino, Y Shibata, J Schalkwijk, M Ogawa
Primary Institution: Kumamoto University Medical School
Hypothesis
The study investigates the expression of SKALP/elafin in squamous cell carcinoma of the oesophagus and its relationship with tumor differentiation.
Conclusion
The expression of SKALP/elafin is significantly related to the differentiation of squamous cell carcinoma of the oesophagus.
Supporting Evidence
- SKALP/elafin expression was localized in the cells of the stratified zone adjacent to PCNA-positive basal cells in non-malignant oesophageal mucosa.
- 73.5% of oesophageal carcinomas showed immunoreactivity with anti-SKALP/elafin serum.
- The expression of SKALP/elafin was found in all well-differentiated squamous cell carcinoma specimens.
- Undifferentiated carcinoma cells did not express SKALP/elafin at all.
Takeaway
This study looked at a protein called SKALP/elafin in cancer cells of the esophagus and found that it is more common in better-differentiated tumors.
Methodology
Immunohistochemical staining was performed on tissue samples from oesophageal carcinoma and non-malignant mucosa to evaluate SKALP/elafin expression.
Limitations
The study did not find a relationship between SKALP/elafin expression and other clinicopathological factors such as depth of invasion and lymph node metastasis.
Participant Demographics
The study included 34 patients, consisting of 30 men and 4 women, with an average age of 64.1 years.
Statistical Information
P-Value
0.010
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website